Published in Ther Clin Risk Manag on December 01, 2007
[Not Available]. Ther Clin Risk Manag (2007) 0.75
Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol (1994) 10.17
Atopic dermatitis. Lancet (2003) 4.14
Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents. J Am Acad Dermatol (2002) 2.41
Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol (2006) 2.09
Patient perspectives on the management of atopic dermatitis. J Allergy Clin Immunol (2006) 1.55
Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug. J Allergy Clin Immunol (2002) 1.29
Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Pediatrics (2002) 1.22
Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol (2002) 1.21
Frequency of atopic dermatitis and relevance of food allergy in adults in Germany. Acta Derm Venereol (2006) 1.09
Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants. J Pediatr (2003) 1.08
Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus. Int J Pharm (2004) 1.07
First experience of topical SDZ ASM 981 in children with atopic dermatitis. Br J Dermatol (2001) 0.96
Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells. J Invest Dermatol (2004) 0.94
Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Dermatology (2005) 0.93
Long-term efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitis. Dermatology (2004) 0.93
Pimecrolimus permeates less than tacrolimus through normal, inflamed, or corticosteroid-pretreated skin. Exp Dermatol (2005) 0.91
Discovery of topical calcineurin inhibitors and pharmacological profile of pimecrolimus. Int Arch Allergy Immunol (2006) 0.90
Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis. Am J Clin Dermatol (2005) 0.89
Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: a two-year study. J Am Acad Dermatol (2005) 0.88
The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils. J Allergy Clin Immunol (2001) 0.88
The "black box" warning and allergy drugs. J Allergy Clin Immunol (2006) 0.88
Low systemic absorption and good tolerability of pimecrolimus, administered as 1% cream (Elidel) in infants with atopic dermatitis--a multicenter, 3-week, open-label study. Pediatr Dermatol (2005) 0.84
Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: a randomized, investigator-blind comparison. J Am Acad Dermatol (2005) 0.84
Pimecrolimus does not affect Langerhans cells in murine epidermis. Br J Dermatol (2003) 0.84
Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life. J Eur Acad Dermatol Venereol (2006) 0.79
Elidel (pimecrolimus) cream 1%: a nonsteroidal topical agent for the treatment of atopic dermatitis. J Allergy Clin Immunol (2003) 0.78
[Post-marketing surveillance on treatment of 5,665 patients with atopic dermatitis using the calcineurin inhibitor pimecrolimus: positive effects on major symptoms of atopic dermatitis and on quality of life]. J Dtsch Dermatol Ges (2006) 0.78
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol (2010) 5.80
Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol (2010) 3.12
Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. Nat Med (2005) 2.92
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. J Allergy Clin Immunol (2011) 2.29
Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol (2006) 2.09
Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol (2006) 2.00
High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J Allergy Clin Immunol (2009) 1.98
Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol (2007) 1.87
Interleukin-17A promotes IgE production in human B cells. J Invest Dermatol (2010) 1.79
Acupuncture in patients with seasonal allergic rhinitis: a randomized trial. Ann Intern Med (2013) 1.76
Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009. Allergy (2009) 1.65
Diagnosis and treatment of urticaria and angioedema: a worldwide perspective. World Allergy Organ J (2012) 1.58
A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J (2013) 1.51
Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB. Hypertension (2010) 1.50
The German Multicentre Study on Multiple Chemical Sensitivity (MCS). Int J Hyg Environ Health (2008) 1.45
2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis. Curr Opin Allergy Clin Immunol (2012) 1.36
World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base. Int Arch Allergy Immunol (2013) 1.31
1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells. Eur J Immunol (2008) 1.25
Variants in a novel epidermal collagen gene (COL29A1) are associated with atopic dermatitis. PLoS Biol (2007) 1.21
Unmet needs in severe chronic upper airway disease (SCUAD). J Allergy Clin Immunol (2009) 1.16
Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis. J Allergy Clin Immunol (2011) 1.15
Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria. Int Arch Allergy Immunol (2010) 1.15
Effect of sildenafil on digital ulcers in systemic sclerosis: analysis from a single centre pilot study. Ann Rheum Dis (2009) 1.13
Control of Pseudomonas aeruginosa skin infections in mice is mast cell-dependent. Am J Pathol (2007) 1.10
Redefinition of the human mast cell transcriptome by deep-CAGE sequencing. Blood (2014) 1.09
Frequency of atopic dermatitis and relevance of food allergy in adults in Germany. Acta Derm Venereol (2006) 1.09
Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features. Arthritis Res Ther (2011) 1.09
Implementation of anaphylaxis management guidelines: a register-based study. PLoS One (2012) 1.05
Provoking allergens and treatment of anaphylaxis in children and adolescents--data from the anaphylaxis registry of German-speaking countries. Pediatr Allergy Immunol (2011) 1.04
Consensus statement on the management of urticaria. Indian J Dermatol (2011) 1.04
Sub-lingual immunotherapy: world allergy organization position paper 2009. World Allergy Organ J (2009) 1.03
Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands. Exp Dermatol (2009) 1.02
[AWMF Guideline no. 013/066. Diagnosis and therapy of circumscribed scleroderma]. J Dtsch Dermatol Ges (2009) 1.02
Physical urticarias and cholinergic urticaria. Immunol Allergy Clin North Am (2013) 1.02
Clopidogrel-associated angioedema. Am J Med (2003) 1.01
Density-equalizing mapping and scientometric benchmarking of European allergy research. J Occup Med Toxicol (2010) 1.01
Uncontrolled allergic rhinitis during treatment and its impact on quality of life: a cluster randomized trial. J Allergy Clin Immunol (2010) 1.00
Induction of long-lived allergen-specific plasma cells by mucosal allergen challenge. J Allergy Clin Immunol (2009) 1.00
Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clin Transl Allergy (2012) 0.97
Mast cell lines HMC-1 and LAD2 in comparison with mature human skin mast cells--drastically reduced levels of tryptase and chymase in mast cell lines. Exp Dermatol (2010) 0.95
Immunoglobulin E-reactivity of wheat-allergic subjects (baker's asthma, food allergy, wheat-dependent, exercise-induced anaphylaxis) to wheat protein fractions with different solubility and digestibility. Mol Nutr Food Res (2004) 0.94
1alpha,25-dihydroxyvitamin D3 inhibits anti-CD40 plus IL-4-mediated IgE production in vitro. Eur J Immunol (2002) 0.94
Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis. Arthritis Res Ther (2014) 0.94
Understanding the complexity of IgE-related phenotypes from childhood to young adulthood: a Mechanisms of the Development of Allergy (MeDALL) seminar. J Allergy Clin Immunol (2012) 0.93
The role of interleukin-1 in allergy-related disorders. Curr Opin Allergy Clin Immunol (2012) 0.93
Safety of a rush immunotherapy build-up schedule with depigmented polymerized allergen extracts. Allergy Asthma Proc (2010) 0.93
Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule. J Clin Oncol (2002) 0.93
Long-term efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitis. Dermatology (2004) 0.93
Introducing genetic testing for adult-type hypolactasia. Digestion (2005) 0.91
Increased sensitivity of patch testing by standardized tape stripping beforehand: a multicentre diagnostic accuracy study. Contact Dermatitis (2010) 0.91
Systemic PPARgamma ligation inhibits allergic immune response in the skin. J Invest Dermatol (2008) 0.89
Efficacy of desloratadine in persistent allergic rhinitis - a GA²LEN study. Int Arch Allergy Immunol (2010) 0.88
Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis. J Allergy Clin Immunol (2012) 0.88
Allergic rhinitis and asthma: a large cross-sectional study in the United Arab Emirates. Int Arch Allergy Immunol (2010) 0.88
Non-pathogenic commensal Escherichia coli bacteria can inhibit degranulation of mast cells. Exp Dermatol (2008) 0.88
Randomized controlled trial of desloratadine for persistent allergic rhinitis: correlations between symptom improvement and quality of life. Allergy Asthma Proc (2013) 0.87
Skin testing with food allergens. Guideline of the German Society of Allergology and Clinical Immunology (DGAKI), the Physicians' Association of German Allergologists (ADA) and the Society of Pediatric Allergology (GPA) together with the Swiss Society of Allergology. J Dtsch Dermatol Ges (2008) 0.87
Vitamin D receptor binds to the ε germline gene promoter and exhibits transrepressive activity. J Allergy Clin Immunol (2010) 0.86
Exogenous histamine aggravates eczema in a subgroup of patients with atopic dermatitis. Acta Derm Venereol (2009) 0.86
Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review. Curr Med Res Opin (2011) 0.86
Guideline on the management of hand eczema ICD-10 Code: L20. L23. L24. L25. L30. J Dtsch Dermatol Ges (2009) 0.86
[Atopic dermatitis: S2 guidelines]. J Dtsch Dermatol Ges (2009) 0.86
Role of adverse reactions to food in urticaria and exercise-induced anaphylaxis. Int Arch Allergy Immunol (2002) 0.86
Vitamin D receptor activation improves allergen-triggered eczema in mice. J Invest Dermatol (2011) 0.86
Inhibition of IgE production by docosahexaenoic acid is mediated by direct interference with STAT6 and NFκB pathway in human B cells. J Nutr Biochem (2010) 0.85
Cabbage allergy: a rare cause of food-induced anaphylaxis. Acta Derm Venereol (2013) 0.85
A nematode immunomodulator suppresses grass pollen-specific allergic responses by controlling excessive Th2 inflammation. Int J Parasitol (2012) 0.85
Liver X receptors control IgE expression in B cells. J Immunol (2009) 0.85
The placebo effect in allergen-specific immunotherapy trials. Clin Transl Allergy (2013) 0.85
Baseline and stimulated turnover of cell surface c-Kit expression in different types of human mast cells. Exp Dermatol (2006) 0.84
Diagnostic approach for suspected pseudoallergic reaction to food ingredients. J Dtsch Dermatol Ges (2008) 0.84
The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens: a Global Allergy and Asthma European Network (GA(2)LEN) article. J Allergy Clin Immunol (2010) 0.84
Successful treatment of cutaneous mastocytosis and Ménière disease with anti-IgE therapy. J Allergy Clin Immunol (2007) 0.84
Evidence for a restricted rather than generalized stimulatory response of skin-derived human mast cells to substance P. J Neuroimmunol (2005) 0.84
Measurement of proliferative responses of cultured lymphocytes. Curr Protoc Immunol (2011) 0.84
Human mast cells in the neurohormonal network: expression of POMC, detection of precursor proteases, and evidence for IgE-dependent secretion of alpha-MSH. J Invest Dermatol (2006) 0.84
Development of alopecia areata universalis in a patient receiving adalimumab. Arch Dermatol (2006) 0.84
The longest wheal diameter is the optimal measurement for the evaluation of skin prick tests. Int Arch Allergy Immunol (2009) 0.84
Modern approaches to the diagnosis and treatment of cold contact urticaria. Curr Allergy Asthma Rep (2010) 0.83
Decreased retinoid concentration and retinoid signalling pathways in human atopic dermatitis. Exp Dermatol (2011) 0.83
100 years of immunotherapy: the Monaco charter. under the high patronage of His Serene Highness Prince Albert II of Monaco. Int Arch Allergy Immunol (2012) 0.83
Aromatic components of food as novel eliciting factors of pseudoallergic reactions in chronic urticaria. J Allergy Clin Immunol (2002) 0.83
A cold-response index for the assessment of Raynaud's phenomenon. J Dermatol Sci (2006) 0.82
Perioral dermatitis. J Dtsch Dermatol Ges (2010) 0.82
Autocrine IL-10 promotes human B-cell differentiation into IgM- or IgG-secreting plasmablasts. Eur J Immunol (2014) 0.82
Inhibition of IgE production by the imidazoquinoline resiquimod in nonallergic and allergic donors. J Invest Dermatol (2002) 0.82
Rituximab preserves vision in ocular mucous membrane pemphigoid. Expert Opin Biol Ther (2015) 0.81
Reactive oxygen species and the bacteriostatic and bactericidal effects of isoconazole nitrate. Mycoses (2013) 0.81
Evidence for novel tomato seed allergens: IgE-reactive legumin and vicilin proteins identified by multidimensional protein fractionation-mass spectrometry and in silico epitope modeling. J Proteome Res (2009) 0.81
1,25-dihydroxyvitamin D3 impairs NF-κB activation in human naïve B cells. Biochem Biophys Res Commun (2011) 0.81
Effects of antihistamines on innate immune responses to severe bacterial infection in mice. Int Arch Allergy Immunol (2011) 0.81
[In vitro allergy diagnosis. Guideline of the German Society of Asthma and Immunology in conjunction with the German Society of Dermatology]. J Dtsch Dermatol Ges (2006) 0.81
Impact of arbuscular mycorrhizal fungi on the allergenic potential of tomato. Mycorrhiza (2010) 0.81
The European Competence Network on Mastocytosis (ECNM). Wien Klin Wochenschr (2004) 0.81
A randomized, double-blind, vehicle-controlled study of 1% pimecrolimus cream in adult patients with perioral dermatitis. J Am Acad Dermatol (2008) 0.81